These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24736279)

  • 21. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.
    Parati G; Schumacher H
    Hypertens Res; 2014 Mar; 37(3):187-93. PubMed ID: 24305518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial.
    Christensen A; Christrup LL; Fabricius PE; Chrostowska M; Wronka M; Narkiewicz K; Hansen EH
    J Hypertens; 2010 Jan; 28(1):194-200. PubMed ID: 19770778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.
    Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
    Hypertens Res; 2013 Jul; 36(7):627-33. PubMed ID: 23344134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet effect of losartan and telmisartan in patients with ischemic stroke.
    Yamada K; Hirayama T; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2007; 16(5):225-31. PubMed ID: 17845921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
    Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
    J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term prognostic implications of visit-to-visit blood pressure variability in patients with ischemic stroke.
    Lau KK; Wong YK; Teo KC; Chang RS; Chan KH; Hon SF; Wat KL; Cheung RT; Li LS; Siu CW; Tse HF
    Am J Hypertens; 2014 Dec; 27(12):1486-94. PubMed ID: 24842389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of stroke in patients with hypertension.
    Dahlöf B
    Am J Cardiol; 2007 Aug; 100(3A):17J-24J. PubMed ID: 17666193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.
    Howard SC; Rothwell PM
    Cerebrovasc Dis; 2009; 28(4):331-40. PubMed ID: 19628934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of a single-pill combination of telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with moderate to severe hypertension: a subgroup analysis of a randomized, double-blind, active-controlled trial.
    Zhu DL; Gao PJ; Liu SW; Jeong MH; Mattheus M; Birgit V
    Chin Med J (Engl); 2013 Nov; 126(21):4072-7. PubMed ID: 24229676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replacing the mercury manometer with an oscillometric device in a hypertension clinic: implications for clinical decision making.
    Stergiou GS; Lourida P; Tzamouranis D
    J Hum Hypertens; 2011 Nov; 25(11):692-8. PubMed ID: 21107434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients.
    Zhu D; Gao P; Holtbruegge W; Huang C
    J Int Med Res; 2014 Feb; 42(1):52-66. PubMed ID: 24391142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.